Multicenter experience with boceprevir or telaprevir to treat hepatitis c recurrence after liver transplantation: when present becomes past, what lessons for future?

HIGHLIGHTS

  • who: Audrey Coilly and collaborators from the Editor:, d'hépatologie, hôpital Henri-Mondor, AP-HP, Créteil, France have published the research work: Multicenter Experience with Boceprevir or Telaprevir to Treat Hepatitis C Recurrence after Liver Transplantation: When Present Becomes Past, What Lessons for Future?, in the Journal: PLOS ONE | DOI:10.1371/journal.pone [0138091]. September 22, 2015 of /1371/
  • what: The aim of this study was to describe factors for efficacy as a function of the SVR24 and safety of triple therapy based on first generation PI to treat HCV recurrence . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?